Developing and Validating a Machine Learning Model to Predict Brain Injury in Preterm Infants Using Multisource Data

Pu Xu1,2, Ying Li2, Ying Chen2

  • 1Capital Institute of Pediatrics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100020, China.

Insights

A new machine learning model effectively predicts preterm brain injury (PBI) using routine clinical data, aiding early risk stratification for vulnerable infants and improving neurodevelopmental outcomes.

Area of Science:

  • Neonatal neurology
  • Machine learning in medicine
  • Computational biology

Background:

  • Moderate-to-severe preterm brain injury (PBI), including intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL), is a major cause of poor neurodevelopmental outcomes in preterm infants.
  • Early identification of at-risk infants through risk stratification is crucial for timely intervention and improved outcomes.

Purpose of the Study:

  • To develop and validate a machine learning model for early risk stratification of preterm brain injury (PBI).
  • To identify key clinical predictors for PBI in preterm infants using routinely collected data.

Main Methods:

  • Retrospective analysis of 318 preterm infants (development cohort) and 35 infants (external validation cohort).
  • Evaluation of 33 candidate predictors from perinatal factors, early laboratory tests, and hospitalization data.
  • Development and comparison of seven machine-learning algorithms, with LightGBM selected for final analysis.
  • Nested cross-validation, Platt scaling for calibration, and assessment using AUROC, PR-AUC, and Brier score.

Main Results:

  • The LightGBM model demonstrated moderate internal discrimination with an AUROC of 0.747.
  • Key predictors included ventilation status and early physiological and laboratory indicators.
  • Preliminary external validation showed a high AUROC (0.897), though with limitations due to small sample size and wide confidence intervals.

Conclusions:

  • An interpretable LightGBM model was developed for PBI risk stratification using readily available early data.
  • The model shows potential for clinical utility, with moderate internal performance and positive net benefit.
  • Larger multicenter studies are necessary to confirm generalizability and refine the model for routine clinical implementation.
Abstract

Related Concept Videos